Literature DB >> 2831722

Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors.

T Gansler1, K D Allen, C F Burant, T Inabnett, A Scott, M G Buse, D A Sens, A J Garvin.   

Abstract

Insulinlike growth factors (IGFs) are peptide hormones that regulate proliferation and differentiation of several types of normal and neoplastic cells. Recent studies of Wilms' tumor, a childhood kidney neoplasm, have detected increased expression of IGF-2 mRNA and protein. The present report describes detection of Type 1 IGF receptors in specimens of Wilms' tumor and adjacent nonneoplastic kidney tissue. These receptors recognize both IGF-1 and IGF-2, and binding of either peptide activates endogenous tyrosine kinase activity of the Type 1 IGF receptor beta subunit. These data indicate that Wilms' tumors contain receptors that recognize and respond to exogenous IGF in vitro, and that autocrine IGF production might contribute to the increased proliferation and abnormal differentiation of these cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831722      PMCID: PMC1880681     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides.

Authors:  J E De Larco; G J Tadaro
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

Review 2.  Actions of insulin-like growth factors.

Authors:  E R Froesch; C Schmid; J Schwander; J Zapf
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

3.  Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor.

Authors:  J J Van Wyk; D C Graves; S J Casella; S Jacobs
Journal:  J Clin Endocrinol Metab       Date:  1985-10       Impact factor: 5.958

4.  The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.

Authors:  J Massagué; M P Czech
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

5.  Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking.

Authors:  M Kasuga; E Van Obberghen; S P Nissley; M M Rechler
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

6.  Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.

Authors:  L Nagarajan; W B Anderson; S P Nissley; M M Rechler; A M Jetten
Journal:  J Cell Physiol       Date:  1985-08       Impact factor: 6.384

7.  The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells.

Authors:  C Mottola; M P Czech
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

8.  Phosphorylation of insulin receptors solubilized from rat skeletal muscle.

Authors:  C F Burant; M K Treutelaar; G E Landreth; M G Buse
Journal:  Diabetes       Date:  1984-07       Impact factor: 9.461

9.  Insulin-like growth factor II receptor as a multifunctional binding protein.

Authors:  D O Morgan; J C Edman; D N Standring; V A Fried; M C Smith; R A Roth; W J Rutter
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

10.  Expression of insulin-like growth factor-II transcripts in Wilms' tumour.

Authors:  A E Reeve; M R Eccles; R J Wilkins; G I Bell; L J Millow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

View more
  12 in total

Review 1.  Polypeptide growth factors and the kidney: a developmental perspective.

Authors:  E D Avner
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

2.  IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.

Authors:  W Zumkeller; A Mahmood; R Dellow; P N Schofield
Journal:  Clin Mol Pathol       Date:  1995-12

3.  Serum-free culture and characterization of renal epithelial cells isolated from human fetal kidneys of varying gestational age.

Authors:  D J Hazen-Martin; B I Tarnowski; J H Todd; M A Sens; J E Bylander; B J Smyth; A J Garvin; D A Sens
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

4.  Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.

Authors:  T Gansler; R Furlanetto; T S Gramling; K A Robinson; N Blocker; M G Buse; D A Sens; A J Garvin
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

5.  novH: differential expression in developing kidney and Wilm's tumors.

Authors:  G Chevalier; H Yeger; C Martinerie; M Laurent; J Alami; P N Schofield; B Perbal
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

6.  Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.

Authors:  D J Hazen-Martin; G G Re; A J Garvin; D A Sens
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

7.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

Authors:  H Werner; G G Re; I A Drummond; V P Sukhatme; F J Rauscher; D A Sens; A J Garvin; D LeRoith; C T Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

8.  Morphology and growth characteristics of epithelial cells from classic Wilms' tumors.

Authors:  D J Hazen-Martin; A J Garvin; T Gansler; B I Tarnowski; D A Sens
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

9.  Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation.

Authors:  J Trojan; T R Johnson; S D Rudin; B K Blossey; K M Kelley; A Shevelev; F W Abdul-Karim; D D Anthony; M L Tykocinski; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 10.  The role of IGF-1R in pediatric malignancies.

Authors:  Su Young Kim; Jeffrey A Toretsky; Daniel Scher; Lee J Helman
Journal:  Oncologist       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.